DE59108366D1 - Verfahren zur Bestimmung eines Analyten - Google Patents

Verfahren zur Bestimmung eines Analyten

Info

Publication number
DE59108366D1
DE59108366D1 DE59108366T DE59108366T DE59108366D1 DE 59108366 D1 DE59108366 D1 DE 59108366D1 DE 59108366 T DE59108366 T DE 59108366T DE 59108366 T DE59108366 T DE 59108366T DE 59108366 D1 DE59108366 D1 DE 59108366D1
Authority
DE
Germany
Prior art keywords
assays
analyte
determining
solid
phase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE59108366T
Other languages
English (en)
Inventor
Thomas Dr Wissel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6420957&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE59108366(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DE59108366T priority Critical patent/DE59108366D1/de
Application granted granted Critical
Publication of DE59108366D1 publication Critical patent/DE59108366D1/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • G01N33/54333Modification of conditions of immunological binding reaction, e.g. use of more than one type of particle, use of chemical agents to improve binding, choice of incubation time or application of magnetic field during binding reaction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/54326Magnetic particles
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/962Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/80Fluorescent dyes, e.g. rhodamine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/804Radioisotope, e.g. radioimmunoassay
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/805Optical property
DE59108366T 1990-12-21 1991-12-20 Verfahren zur Bestimmung eines Analyten Revoked DE59108366D1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE59108366T DE59108366D1 (de) 1990-12-21 1991-12-20 Verfahren zur Bestimmung eines Analyten

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4041080A DE4041080A1 (de) 1990-12-21 1990-12-21 Verfahren zur bestimmung eines analyten
DE59108366T DE59108366D1 (de) 1990-12-21 1991-12-20 Verfahren zur Bestimmung eines Analyten

Publications (1)

Publication Number Publication Date
DE59108366D1 true DE59108366D1 (de) 1997-01-02

Family

ID=6420957

Family Applications (2)

Application Number Title Priority Date Filing Date
DE4041080A Withdrawn DE4041080A1 (de) 1990-12-21 1990-12-21 Verfahren zur bestimmung eines analyten
DE59108366T Revoked DE59108366D1 (de) 1990-12-21 1991-12-20 Verfahren zur Bestimmung eines Analyten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE4041080A Withdrawn DE4041080A1 (de) 1990-12-21 1990-12-21 Verfahren zur bestimmung eines analyten

Country Status (9)

Country Link
US (2) US7029856B1 (de)
EP (1) EP0492499B1 (de)
JP (1) JP3290193B2 (de)
AT (1) ATE145480T1 (de)
AU (1) AU657719B2 (de)
CA (1) CA2058175C (de)
DE (2) DE4041080A1 (de)
DK (1) DK0492499T3 (de)
ES (1) ES2094784T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0488152A3 (en) * 1990-11-30 1992-11-25 Hitachi, Ltd. Method for immunoassay and apparatus therefor
DE4041080A1 (de) * 1990-12-21 1992-06-25 Behringwerke Ag Verfahren zur bestimmung eines analyten
JP3353978B2 (ja) * 1993-12-06 2002-12-09 オリンパス光学工業株式会社 光学的特異親和性測定方法及びこれに用いられる特異親和性測定装置
US5856194A (en) 1996-09-19 1999-01-05 Abbott Laboratories Method for determination of item of interest in a sample
US5795784A (en) 1996-09-19 1998-08-18 Abbott Laboratories Method of performing a process for determining an item of interest in a sample
WO2008106648A2 (en) * 2007-03-01 2008-09-04 Abbott Laboratories Immunoassays exhibiting a reduction in prozone phenomena
US20090104634A1 (en) * 2007-10-21 2009-04-23 Abbott Laboratories One-step immunoassays exhibiting increased sensitivity and specificity
US20100267055A1 (en) * 2007-10-21 2010-10-21 Abbott Laboratories One-step immunoassays exhibiting increased sensitivity and specificity
US8222048B2 (en) 2007-11-05 2012-07-17 Abbott Laboratories Automated analyzer for clinical laboratory
CN113125740B (zh) * 2021-05-17 2022-03-01 郑州安图生物工程股份有限公司 化学发光免疫分析技术中磁微粒活化效率的鉴定方法

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933997A (en) 1974-03-01 1976-01-20 Corning Glass Works Solid phase radioimmunoassay of digoxin
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
US4018886A (en) 1975-07-01 1977-04-19 General Electric Company Diagnostic method and device employing protein-coated magnetic particles
US3970518A (en) 1975-07-01 1976-07-20 General Electric Company Magnetic separation of biological particles
SE404553B (sv) 1977-03-04 1978-10-09 Pharmacia Diagnostics Ab Sett vid bestemningsmetoder involverande biospecifika affinitetsreaktioner
US4576912A (en) * 1978-11-30 1986-03-18 Technicon Instruments Corporation Fluoroimmunoassaying
US4297337A (en) 1979-04-13 1981-10-27 Corning Glass Works Solid-phase immunoassays using magnetic glass
EP0030087A1 (de) 1979-11-13 1981-06-10 Technicon Instruments Company Limited Immunoassay-Verfahren und -Vorrichtung und Ausrüstung zur Durchführung des Verfahrens
AU543007B2 (en) * 1980-04-15 1985-03-28 Technicon Instruments Corportion Agglutination immunoassay
FR2480764B1 (fr) 1980-04-18 1985-10-04 Rhone Poulenc Spec Chim Latex de polymeres magnetiques et procede de preparation
NO155316C (no) 1982-04-23 1987-03-11 Sintef Fremgangsmaate for fremstilling av magnetiske polymerpartikler.
US4628037A (en) 1983-05-12 1986-12-09 Advanced Magnetics, Inc. Binding assays employing magnetic particles
US4554088A (en) 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
CA1220168A (en) 1983-09-09 1987-04-07 Henry J. Rahn Magnetic separator for solid phase immunoassays
GB8401368D0 (en) 1984-01-19 1984-02-22 Amersham Int Plc Assay method
US4687734A (en) * 1984-06-07 1987-08-18 Chester Samuel J Immunoassay for the detection of human colon cancer using a polyclonal antibody derived from a capillary culture of tumor cells
GB8422452D0 (en) 1984-09-05 1984-10-10 Serono Diagnostics Ltd Assay
AU603342B2 (en) 1985-10-15 1990-11-15 Minnesota Mining And Manufacturing Company Chemiluminescent methods and kit
US4780421A (en) 1986-04-03 1988-10-25 Sclavo Inc. Cleavable labels for use in binding assays
DE3645292C2 (de) 1986-08-22 1997-12-11 Hoechst Ag Chemilumineszenzimmunoassays und ein Verfahren zu ihrer Herstellung
US4891324A (en) * 1987-01-07 1990-01-02 Syntex (U.S.A.) Inc. Particle with luminescer for assays
DE3850273T2 (de) 1987-03-02 1994-09-29 Gen Probe Inc Polykationische Träger zur Reinigung, Trennung und Hybridisierung von Nukleinsäure.
US4971904A (en) 1987-06-26 1990-11-20 E. I. Du Pont De Nemours And Company Heterogeneous immunoassay
US4927769A (en) 1987-07-08 1990-05-22 Ciba Corning Diagnostics Corp. Method for enhancement of chemiluminescence
DE3842125A1 (de) * 1987-12-14 1989-06-29 Hitachi Ltd Immunoassay-verfahren und vorrichtung zur durchfuehrung des verfahrens
US6002007A (en) 1988-02-20 1999-12-14 Dade Behring Marburg Gmbh Special chemiluminescent acridine derivatives and the use thereof in luminescence immunoassays
DE3844954C2 (de) 1988-02-20 1998-07-16 Hoechst Ag Spezielle chemilumineszierende Acridinderivate und ihre Verwendung in Lumineszenzimmunoassays
DE3806431A1 (de) * 1988-02-29 1989-09-07 Boehringer Mannheim Gmbh Verfahren zur herstellung einer festphasenmatrix
US5268306A (en) 1988-02-29 1993-12-07 Boehringer Mannheim Gmbh Preparation of a solid phase matrix containing a bound specific binding pair
DE3840462A1 (de) 1988-12-01 1990-06-07 Berthold Lab Prof R Verfahren und vorrichtung zur messung der chemilumineszenz
JPH02198361A (ja) 1989-01-28 1990-08-06 Eiji Ishikawa 迅速・超高感度測定法
US5279936A (en) * 1989-12-22 1994-01-18 Syntex (U.S.A.) Inc. Method of separation employing magnetic particles and second medium
EP0488152A3 (en) * 1990-11-30 1992-11-25 Hitachi, Ltd. Method for immunoassay and apparatus therefor
DE4041080A1 (de) * 1990-12-21 1992-06-25 Behringwerke Ag Verfahren zur bestimmung eines analyten

Also Published As

Publication number Publication date
DK0492499T3 (da) 1997-05-05
JP3290193B2 (ja) 2002-06-10
EP0492499A2 (de) 1992-07-01
AU657719B2 (en) 1995-03-23
AU8989691A (en) 1992-06-25
CA2058175A1 (en) 1992-06-22
ES2094784T3 (es) 1997-02-01
US7700298B2 (en) 2010-04-20
EP0492499B1 (de) 1996-11-20
US7029856B1 (en) 2006-04-18
DE4041080A1 (de) 1992-06-25
EP0492499A3 (en) 1992-11-19
JPH04301764A (ja) 1992-10-26
ATE145480T1 (de) 1996-12-15
US20070026459A1 (en) 2007-02-01
CA2058175C (en) 2004-03-02

Similar Documents

Publication Publication Date Title
IT8249401A0 (it) Metodo per determinare la presenza di analita in soluzione, in particolare per saggi immunologici
EP0384130A3 (de) Herzinfarkt-Immunoassay
DE3486356T2 (de) Von polypeptiden induzierte monoklonale antikörper gegen oncoproteine.
ATE120549T1 (de) Verfahren zur bestimmung von hiv-antikörpern.
DE3576854D1 (de) Immunchemisches messverfahren fuer haptene und proteine.
DE59108366D1 (de) Verfahren zur Bestimmung eines Analyten
ATE79678T1 (de) Bestimmung von monokinen.
DE59511101D1 (de) Metallchelat-markierte peptide
DE3850249D1 (de) Nachweis von analyt in partikel enthaltenden proben.
DE3781582D1 (de) Verfahren und reagenz zur bestimmung eines reaktionspartners einer immunologischen reaktion.
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
DE3776525D1 (de) Immunochemisches verfahren zur bestimmung von stabilem glykosiliertem haemoglobin.
ES511156A0 (es) Un metodo de determinar la presencia de un antigeno en un medio liquido sospechoso de contenerlo.
IL64574A (en) Method for determining the presence of an analyte by determination of the amount of fluorescence in competitive protein binding assays
DE69836713D1 (de) Verfahren zur Verbesserung der Genauigkeit von der semi-quantitativen Bestimmung eines Analyts in flüssigen Proben
DE58907087D1 (de) Verfahren zur Bestimmung von für ein Antigen klassenspezifischen Antikörpern und dazu geeignetes Reagenz.
ATE42836T1 (de) Verfahren und reagenz zur quantitativen bestimmung von freiem thyroxin in plasma, serum oder vollblut.
DE3669078D1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
EP0261493A3 (de) Verfahren zur Bestimmung von Immunglobulinen IgM und IgA und Reagenzien dafür
NO172084C (no) Monoklonalt antistoff, anvendelse derav samt reagenssystem for immunologisk bestemmelse av fritt protein s og c4bp-protein s kompleks
DE59207717D1 (de) Verfahren zur Bestimmung einer immunologisch bindefähigen Substanz
ATE41242T1 (de) Verfahren zur bestimmung einer immunologisch bindefaehigen substanz.
ES2076221T3 (es) Derivados geminales de difenilo y su uso en inmunoensayos.
DE3853315D1 (de) Verfahren zur quantitativen Bestimmung von Serumproteinen in Körperflüssigkeiten und Mittel zur Durchführung des Verfahrens.

Legal Events

Date Code Title Description
8363 Opposition against the patent
8327 Change in the person/name/address of the patent owner

Owner name: BEHRING DIAGNOSTICS GMBH, 35041 MARBURG, DE

8327 Change in the person/name/address of the patent owner

Owner name: DADE BEHRING MARBURG GMBH, 35041 MARBURG, DE

8339 Ceased/non-payment of the annual fee
8331 Complete revocation
8370 Indication related to discontinuation of the patent is to be deleted